Skip to content

DBMed

Active
Private limited companyfounded 201115 yrs activeWinston Churchilllaan 192A, 1180 Ukkel, BelgiumKBO/BCE: BE 0832.797.359
Summary

The computed 12-month bankruptcy probability of DBMed is 2.1% (moderate). The 2025 annual accounts show equity of €497,910 and a net result of €100,466. Equity is growing by ~11.2% per year across the filed fiscal years. The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes · tick = 2024
Profitability90=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
2.1% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €40,000 at 30 days acceptable
Liquidity ample (current ratio 18.75 against 15.02 in 2024; short-term debt: 4.8% and cash: 42.2% of total assets), and 14% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
86%
Return on assets
17.4%
Age of the figures
15 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 15 years 0 20 y
neutral · A punctual record breaks
This company filed 4 consecutive financial years on time. The year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 28-02-2026, 28 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
28 d late
2024
on the day
2023
on the day
2022
13 d early
2021
17 d early
2020
2 d late
2019
1 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average on the deadline day; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 31 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close28-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

DBMed was incorporated on 14 January 2011.1 Total assets rose from EUR 374,471 in 2019 to EUR 578,892 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€497,910▲ 12.7%
2024 · €441,880
Total assets
€578,892▲ 6.1%
2024 · €545,697
Net result
€100,466▲ 6.6%
2024 · €94,260
Working capital
€493,564▲ 12.7%
2024 · €438,020
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€94,076▲ 7,634%€113,203▲ 20.3%€224,016▲ 97.9%€138,060▼ 38.4%€144,621▲ 4.8%
Net result€68,339€81,285▲ 18.9%€153,559▲ 88.9%€94,260▼ 38.6%€100,466▲ 6.6%
Equity€189,787▼ 35.1%€270,534▲ 42.5%€347,620▲ 28.5%€441,880▲ 27.1%€497,910▲ 12.7%
Total assets€401,291▲ 7.6%€390,942▼ 2.6%€536,877▲ 37.3%€545,697▲ 1.6%€578,892▲ 6.1%
Debt€211,504▲ 163%€120,408▼ 43.1%€189,258▲ 57.2%€103,817▼ 45.1%€80,983▼ 22.0%
Working capital€162,271▼ 19.7%€257,716▲ 58.8%€335,176▲ 30.1%€438,020▲ 30.7%€493,564▲ 12.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100,000€200,000Operating result 2021: €94,076€94,076Net result 2021: €68,339€68,339Operating result 2022: €113,203€113,203Net result 2022: €81,285€81,285Operating result 2023: €224,016€224,016Net result 2023: €153,559€153,559Operating result 2024: €138,060€138,060Net result 2024: €94,260€94,260Operating result 2025: €144,621€144,621Net result 2025: €100,466€100,46620212022202320242025€0€100,000€200,000Operating result 2023: €224,016€224,000Net result 2023: €153,559€154,000Operating result 2024: €138,060€138,000Net result 2024: €94,260€94,300Operating result 2025: €144,621€145,000Net result 2025: €100,466€100,000202320242025
The operating result recovers in 2025; 2025 is 5% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €578,892
Fixed assets €57,516 ▼ 24.8%
Current assets €521,376 ▲ 11.1%
Equity and liabilities €578,892
Equity €497,910 ▲ 12.7%
Debt €80,983 ▼ 22.0%
Debt's share of the balance-sheet total falls from 19.0% to 14.0%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€166,033▲
2024 · €164,099
Cash flow
€121,878▲
2024 · €120,299
Current ratio
18.75▲
2024 · 15.02
Debt to equity
0.16▼
2024 · 0.23
ROE
20.2%▼
2024 · 21.3%
ROA
17.4%▲
2024 · 17.3%
Interest coverage
53.29▲
2024 · 32.19
Debt ≤ 1 year
€27,812▼
2024 · €31,236
Debt > 1 year
€53,171▼
2024 · €71,046
Income taxes
€42,524▲
2024 · €39,146
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 17,810 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 97% are still going.

  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.2% went bankrupt
3.1% stopped otherwise
97% still going

For this company itself Checked computes a higher bankruptcy probability: 2.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 17,810 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet Code20242025
Assets
Total assets20/58€545,697€578,892▲
Fixed assets21/28€76,441€57,516▼
Intangible fixed assets21-€0
Tangible fixed assets22/27€76,441€57,516▼
Plant, machinery and equipment23€1,562€1,012▼
Furniture and vehicles24€45,651€32,696▼
Other tangible fixed assets26€29,228€23,808▼
Current assets29/58€469,256€521,376▲
Amounts receivable within one year40/41€156,190€144,521▼
Trade receivables40€129,409€144,521▲
Other amounts receivable41€26,782-
Current investments50/53€0€81,200▲
Cash at bank and in hand54/58€258,993€244,251▼
Deferred charges and accrued income490/1€54,073€51,403▼
Equity and liabilities
Total equity and liabilities10/49€545,697€578,892▲
Equity10/15€441,880€497,910▲
Contributions10/11€12,400-
Reserves13€429,480€497,910▲
Distributable reserves133€429,480€497,910▲
Profit (loss) carried forward14€0-
Amounts payable17/49€103,817€80,983▼
Amounts payable after more than one year17€71,046€53,171▼
Financial debts170/4€71,046€53,171▼
Amounts payable within one year42/48€31,236€27,812▼
Current portion of amounts payable after more than one year42€17,324€17,875▲
Financial debts43€5,042€4,234▼
Credit institutions430/8€5,042€4,234▼
Trade debts44€1,172€368▼
Suppliers440/4€1,172€368▼
Taxes, remuneration and social security45€0€2,140▲
Taxes450/3€0€2,140▲
Other amounts payable47/48€7,698€3,193▼
Accrued charges and deferred income492/3€1,535-
Income statement Code20242025
Non-recurring operating income76A€0-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€26,039€21,412▼
Other operating charges640/8€1,346€766▼
Gross operating margin9900€165,444€166,799▲
Operating profit (loss)9901€138,060€144,621▲
Financial income75/76B€445€1,484▲
Recurring financial income75€445€1,484▲
Financial charges65/66B€5,098€3,116▼
Recurring financial charges65€5,098€3,116▼
Profit (loss) for the period before taxes9903€133,407€142,990▲
Income taxes67/77€39,146€42,524▲
Profit (loss) for the period9904€94,260€100,466▲
Profit (loss) for the period to be appropriated9905€94,260€100,466▲
Appropriation of the result
Profit (loss) to be appropriated9906€94,260€100,466▲
Transfer from equity791/2€0€32,036▲
Transfer to equity691/2€94,260€100,466▲
To other reserves6921€94,260€100,466▲
Profit to be distributed694/7€0€32,036▲
Return on contributions (dividend)694€0€32,036▲

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A--€8,250€0--
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€20,769€20,175€23,262€26,039€21,412▼ 17.8%
Other operating charges640/8-€703€1,281€1,346€766▼ 43.1%
Gross operating margin9900€123,716€134,081€248,558€165,444€166,799▲ 0.8%
Operating profit (loss)9901€94,076€113,203€224,016€138,060€144,621▲ 4.8%
Financial income75/76B--€4€445€1,484▲ 234%
Recurring financial income75€0-€4€445€1,484▲ 234%
Financial charges65/66B-€636€2,033€5,098€3,116▼ 38.9%
Recurring financial charges65€258€636€2,033€5,098€3,116▼ 38.9%
Profit (loss) for the period before taxes9903€93,818€112,567€221,987€133,407€142,990▲ 7.2%
Income taxes67/77€25,479€31,282€68,428€39,146€42,524▲ 8.6%
Profit (loss) for the period9904€68,339€81,285€153,559€94,260€100,466▲ 6.6%
Profit (loss) for the period to be appropriated9905€68,339€81,285€153,559€94,260€100,466▲ 6.6%
Line20212022202320242025Change
Assets
Total assets20/58€401,291€390,942€536,877€545,697€578,892▲ 6.1%
Fixed assets21/28€49,809€65,638€100,831€76,441€57,516▼ 24.8%
Intangible fixed assets21----€0-
Tangible fixed assets22/27€49,809€65,638€100,831€76,441€57,516▼ 24.8%
Plant, machinery and equipment23-€1,274€432€1,562€1,012▼ 35.2%
Furniture and vehicles24-€12,192€60,874€45,651€32,696▼ 28.4%
Other tangible fixed assets26-€52,172€39,525€29,228€23,808▼ 18.5%
Current assets29/58€351,481€325,305€436,046€469,256€521,376▲ 11.1%
Amounts receivable within one year40/41€150,610€129,235€153,129€156,190€144,521▼ 7.5%
Trade receivables40-€122,510€153,129€129,409€144,521▲ 11.7%
Other amounts receivable41-€6,725€0€26,782--
Current investments50/53€195,241€184,771€223,675€0€81,200-
Cash at bank and in hand54/58-€7,241€2,183€258,993€244,251▼ 5.7%
Deferred charges and accrued income490/1-€4,058€57,058€54,073€51,403▼ 4.9%
Equity and liabilities
Total equity and liabilities10/49€401,291€390,942€536,877€545,697€578,892▲ 6.1%
Equity10/15€189,787€270,534€347,620€441,880€497,910▲ 12.7%
Contributions10/11-€12,400€12,400€12,400--
Reserves13€177,387€258,134€335,220€429,480€497,910▲ 15.9%
Distributable reserves133-€258,134€335,220€429,480€497,910▲ 15.9%
Profit (loss) carried forward14--€0€0--
Amounts payable17/49€211,504€120,408€189,258€103,817€80,983▼ 22.0%
Amounts payable after more than one year17€22,293€52,430€88,370€71,046€53,171▼ 25.2%
Financial debts170/4-€52,430€88,370€71,046€53,171▼ 25.2%
Amounts payable within one year42/48€189,211€67,589€100,870€31,236€27,812▼ 11.0%
Current portion of amounts payable after more than one year42-€5,856€18,308€17,324€17,875▲ 3.2%
Financial debts43-€3,683€4,346€5,042€4,234▼ 16.0%
Credit institutions430/8-€3,683€4,346€5,042€4,234▼ 16.0%
Trade debts44€323€704€1,110€1,172€368▼ 68.6%
Suppliers440/4-€704€1,110€1,172€368▼ 68.6%
Taxes, remuneration and social security45--€428€0€2,140-
Taxes450/3--€428€0€2,140-
Other amounts payable47/48-€57,346€76,679€7,698€3,193▼ 58.5%
Accrued charges and deferred income492/3-€389€17€1,535--
Line20212022202320242025Change
Profit (loss) for the period9904€68,339€81,285€153,559€94,260€100,466▲ 6.6%
+ Depreciation and write-downs630€20,769€20,175€23,262€26,039€21,412▼ 17.8%
Operating cash flow (approximation)€89,109€101,460€176,821€120,299€121,878▲ 1.3%
Investment in fixed assets (approximation)--€36,004-€58,455-€1,649-€2,487▼ 50.8%
Change in cash---€5,058€256,809-€14,742▼ 106%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
28-02
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
31-01
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial Liquidity triplescurrent ratio 15.02
Current ratio from 4.32 to 15.02; short-term debt falls from €100,870 to €31,236.
31-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial Highest result since 2019net €153,559 ▲88.9%
Operating result €224,016, net result €153,559, both a record.
18-01
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial Liquidity triplescurrent ratio 4.81
Current ratio from 1.86 to 4.81; short-term debt falls from €189,211 to €67,589.
30-06
Financial Equity above €200,000Eq €270,534 ▲42.5%
2 profitable years in a row build equity to €270,534.
14-01
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
30-06
Financial Back to profitnet €68,339
Net result €68,339 after one loss-making year.
02-02
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 2 days late
2020
30-06
Financial Weakest financial yearnet -€1,538
Net result drops to -€1,538, the lowest in the series; recovery starts the following year.
Show earlier events
30-01
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-01
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
26-01
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
04-01
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts

We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 2 establishment units since 2010
seat establishment All 2 establishment units on the map
Ground area
1.9 ha
Building footprint
1,459 m²
Volume, LiDAR
27,907 m³
2 parcels, Brussels · tallest building 29.5 m, ±9 floors. Linked by address, not a title deed.
6 companies at this address See who is registered here
2 establishment units
DBMed
Winston Churchilllaan 192, 1180 UkkelSpecialist medical practice
since 20102.195.776.627
DBMed
De Frélaan 206, 1180 UkkelSpecialist medical practice
since 20102.195.783.951
2 parcels
Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21612C0286/00Y015 Brussels 1.7 ha 1 · 913 m² 20.4 m · 5 fl.
21612C0003/00E021 Brussels 2,250 m² 1 · 546 m² 29.5 m · 9 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

9845002C0F43C41F9F18
live in the LEI register

Identification & contact

Identification
Legal formPrivate limited company
Founded14-01-2011
Fiscal year end30-06
E-invoicing
Reachable via Peppol
Peppol ID 0208:0832797359
Registered 04-10-2024

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.